High Blood Calcium (Hypercalcemia): Causes, Symptoms, and Treatment

Hypercalcemia (serum calcium >10.5 mg/dL or ionized >5.6 mg/dL) is a common metabolic disorder with diverse etiologies. The two most frequent causes—primary hyperparathyroidism and malignancy—account for >90% of cases.

Etiologic Classification

1. PTH-Mediated

  • Primary hyperparathyroidism (PHPT): Parathyroid adenoma (80–85%), hyperplasia (15%), carcinoma (<1%). High PTH, high Ca²⁺. Asymptomatic or "stones, bones, groans, moans."
  • Familial Hypocalciuric Hypercalcemia (FHH): CASR inactivating mutation → low urine Ca²⁺ (CCCR <0.01), mild hypercalcemia, normal/mildly elevated PTH. Benign; no surgery.
  • Lithium therapy: Shifts Ca²⁺ set-point → mild PHPT-like picture.

2. PTH-Independent (PTH Suppressed)

  • Malignancy:
    • Humoral: PTHrP secretion (squamous cell, breast, renal, ovarian) → 80% of malignancy hypercalcemia.
    • Local osteolysis: Bone metastases (breast, prostate, myeloma) → RANKL-mediated osteoclast activation.
    • Vitamin D-mediated: Lymphomas (1,25-(OH)₂D overproduction).
  • Granulomatous diseases: Sarcoidosis, TB, fungal — macrophage 1α-hydroxylase → ↑1,25-(OH)₂D → ↑gut Ca²⁺ absorption.
  • Endocrine: Thyrotoxicosis (bone turnover), Addison's (hemoconcentration + ↓renal excretion), acromegaly.
  • Drugs: Thiazides (↓Ca²⁺ excretion), vitamin D/A excess, calcium supplements (milk-alkali syndrome), denosumab (rebound).
  • Immobilization: Rapid bone resorption in high-turnover states (adolescents, Paget's).

3. Renal

  • CKD: Usually hypocalcemia; tertiary HPT (autonomous PTH) → hypercalcemia post-transplant.

Clinical Presentation

Symptoms correlate with severity and acuity:

  • Mild (<12 mg/dL): Often asymptomatic; fatigue, polyuria, constipation.
  • Moderate (12–14 mg/dL): Nausea, vomiting, anorexia, confusion, polyuria/polydipsia (nephrogenic DI).
  • Severe (>14 mg/dL): Altered mental status, coma, cardiac arrhythmias (shortened QT), acute kidney injury, pancreatitis.

Diagnostic Workup

  1. Albumin-corrected Ca²⁺ or ionized Ca²⁺ (confirm)
  2. Intact PTH (differentiates PTH-mediated vs. independent)
  3. PTHrP if PTH low + suspicion for malignancy
  4. 25-OH-D, 1,25-(OH)₂D, SPEP/UPEP, TSH, cortisol
  5. Imaging per suspicion (parathyroid sestamibi, CT chest/abdomen, bone survey)

Acute Management (Severe/Symptomatic)

  1. IV 0.9% saline 200–300 mL/hr → target urine >100 mL/hr
  2. Loop diuretic (furosemide) only after volume repletion
  3. Bisphosphonate (zoledronic acid 4 mg IV) or denosumab 120 mg SC — onset 24–48h
  4. Calcitonin 4 IU/kg q12h (rapid but tachyphylaxis in 48h)
  5. Dialysis if renal failure or refractory

Definitive treatment targets the underlying cause (parathyroidectomy for PHPT, cancer-directed therapy, drug cessation, etc.).

Hypertension - Related Articles